{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Shivakoti R"],"funding":["US National Institutes of Health","Boehringer-Ingelheim","Bristol-Myers Squibb","GlaxoSmithKline","US National Institute of Allergy and Infectious Diseases","NIAID NIH HHS","AIDS Clinical Trials Group","Gilead Foundation","Gilead Sciences"],"pagination":["183-189"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4531105"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["35(1)"],"pubmed_abstract":["Background & aims
HIV-infected adults have increased risk of several individual micronutrient deficiencies. However, the prevalence and risk factors of concurrent and multiple micronutrient deficiencies and whether micronutrient concentrations change after antiretroviral therapy (ART) initiation have not been well described. The objective of this study was to determine the prevalence and risk factors of individual, concurrent and multiple micronutrient deficiencies among ART-naïve HIV-infected adults from nine countries and assess change in micronutrient status 48 weeks post-ART initiation.Methods
A random sub-cohort (n = 270) stratified by country was selected from the multinational PEARLS clinical trial (n = 1571 ART-naïve, HIV-infected adults). We measured serum concentr"],"journal":["Clinical nutrition (Edinburgh, Scotland)"],"pubmed_title":["Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults."],"pmcid":["PMC4531105"],"funding_grant_id":["UM1 AI106701","UM1 AI069423","R01 AI045462","UM1 AI069436","UM1 AI069424","UM1 AI068634","U01 AI069450","UM1 AI068636","R01 AI080417","AI069450","R01 AI080417 to AG","U01 AI068636","AI68636","P30 AI042853","UM1 AI069450","UM1 AI069465","UM1 AI069476"],"pubmed_authors":["Gupte N","Cardoso SW","Poongulali S","Riviere C","Kanyama C","Tang AM","Christian P","Semba RD","Gupta A","Yang WT","Pillay S","Santos B","Lama JR","Sugandhavesa P","Samaneka W","Shivakoti R","Tripathy S","Berendes S","Mwelase N","Campbell TB","NWCS 319 and PEARLS Study Team"],"additional_accession":[]},"is_claimable":false,"name":"Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults.","description":"Background & aims
HIV-infected adults have increased risk of several individual micronutrient deficiencies. However, the prevalence and risk factors of concurrent and multiple micronutrient deficiencies and whether micronutrient concentrations change after antiretroviral therapy (ART) initiation have not been well described. The objective of this study was to determine the prevalence and risk factors of individual, concurrent and multiple micronutrient deficiencies among ART-naïve HIV-infected adults from nine countries and assess change in micronutrient status 48 weeks post-ART initiation.Methods
A random sub-cohort (n = 270) stratified by country was selected from the multinational PEARLS clinical trial (n = 1571 ART-naïve, HIV-infected adults). We measured serum concentr","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Feb","modification":"2025-04-22T16:10:22.963Z","creation":"2019-03-27T01:56:33Z"},"accession":"S-EPMC4531105","cross_references":{"pubmed":["25703452"],"doi":["10.1016/j.clnu.2015.02.002"]}}